Literature DB >> 17889412

Solid organ transplantation and response to vaccination.

Beatriz Serrano1, Jose-María Bayas, Laia Bruni, Consolación Díez.   

Abstract

Although early vaccination is recommended in candidates for solid organ transplantation (SOT), consensual protocols do not yet exist. We applied an SOT vaccination protocol in the Hospital Clinic of Barcelona (Spain). Serology was performed before and after vaccination and compliance with the vaccination schedule was analysed during the period 2003-2004. Two hundred and thirty seven patients (72.9% male; mean age 56.31 years, range 19-72) were included. A total of 74.5% of subjects susceptible to hepatitis B virus infection responded to hepatitis B vaccination. Most patients were protected against hepatitis A, varicella, measles, rubella and mumps. The vaccine protocol was implemented satisfactorily and the administration of two courses of hepatitis B vaccine was shown to be effective.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889412     DOI: 10.1016/j.vaccine.2007.08.031

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation.

Authors:  Arianeb Mehrabi; Majid Esmaeilzadeh; Hamidreza Fonouni; Mohammadreza Hafezi; Nuh N Rahbari; Mohammad Golriz; Ali Majlesara; Morva Tahmasbi Rad; Mahmoud Sadeghi; Jan Schmidt; Tom M Ganten
Journal:  Langenbecks Arch Surg       Date:  2011-05-02       Impact factor: 3.445

2.  Immunogenicity of Four Doses of Double-Strength Intramuscular Hepatitis B.

Authors:  Seyed Ali Asghar Fakhrmousavi; Azar Hadadi; Seyed Hamed Hosseini; Maryam Rahbar; Reza Hamidian; Amitis Ramezani; Gholamreza Pourmand; Effat Razeghi
Journal:  Iran J Pathol       Date:  2016

3.  Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.

Authors:  Ayelet Grupper; Liane Rabinowich; Doron Schwartz; Idit F Schwartz; Merav Ben-Yehoyada; Moshe Shashar; Eugene Katchman; Tami Halperin; Dan Turner; Yaacov Goykhman; Oren Shibolet; Sharon Levy; Inbal Houri; Roni Baruch; Helena Katchman
Journal:  Am J Transplant       Date:  2021-05-07       Impact factor: 9.369

4.  An Analysis of Serological Response and Infection Outcomes Following Oxford-AstraZeneca (AZD1222) and Pfizer-BioNTech (mRNA BNT162b2) SARS-CoV-2 Vaccines in Kidney and Kidney-pancreas Transplants.

Authors:  Argiris Asderakis; Usman Khalid; Georgios Koimtzis; Mark J Ponsford; Laszlo Szabo; Christopher Chalklin; Kathryn Bramhall; Leanne Grant; Stuart J Moat; Ian R Humphreys; Stephen R Jolles
Journal:  Transplantation       Date:  2022-03-08       Impact factor: 5.385

5.  Immune Complex Mediated Glomerulonephritis with Acute Thrombotic Microangiopathy following Newly Detected Hepatitis B Virus Infection in a Kidney Transplant Recipient.

Authors:  Tracey Salter; Hannah Burton; Sam Douthwaite; William Newsholme; Catherine Horsfield; Rachel Hilton
Journal:  Case Rep Transplant       Date:  2016-10-09

Review 6.  SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses.

Authors:  Ayelet Grupper; Helena Katchman
Journal:  Curr Transplant Rep       Date:  2022-01-22

7. 

Authors:  Hans-Jürgen Laws; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Maximilian Christopeit; Jane Hecht; Ulrich Heininger; Inken Hilgendorf; Winfried Kern; Kerstin Kling; Guido Kobbe; Wiebe Külper; Thomas Lehrnbecher; Roland Meisel; Arne Simon; Andrew Ullmann; Maike de Wit; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-05       Impact factor: 1.513

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.